HLF logo

Herbalife Ltd. Stock Price

NYSE:HLF Community·US$1.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 32 Fair Values set on narratives written by author

HLF Share Price Performance

US$13.11
3.47 (36.00%)
US$18.33
Fair Value
US$13.11
3.47 (36.00%)
28.5% undervalued intrinsic discount
US$18.33
Fair Value
Price US$13.11
AnalystConsensusTarget US$18.33
AnalystHighTarget US$25.00
AnalystLowTarget US$9.00

HLF Community Narratives

·
Fair Value US$18.33 28.5% undervalued intrinsic discount

Global Regulatory Scrutiny Will Undermine MLM And Supplement Models

1users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
·
Fair Value US$25 47.6% undervalued intrinsic discount

Digital Platforms And Personalized Nutrition Will Expand Wellness Despite Headwinds

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$9 45.7% overvalued intrinsic discount

Intensifying Regulatory Pressures And Distributor Disruptions Will Imperil Future Prospects

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$18.33
28.5% undervalued intrinsic discount
Revenue
2.87% p.a.
Profit Margin
5.68%
Future PE
8.19x
Price in 2029
US$24.66

Trending Discussion

Updated Narratives

HLF logo

HLF: Execution On 2026 Guidance And Margins Will Drive Stock Rebound

Fair Value: US$18.33 28.5% undervalued intrinsic discount
9 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HLF logo

HLF: Refinancing And Margin Improvement Will Support Turnaround Despite Weak EBITDA Guidance

Fair Value: US$25 47.6% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HLF logo

HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures

Fair Value: US$9 45.7% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with low risk.

3 Risks
3 Rewards

Herbalife Ltd. Key Details

US$5.1b

Revenue

US$1.1b

Cost of Revenue

US$4.0b

Gross Profit

US$3.8b

Other Expenses

US$239.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 05, 2026
2.31
77.78%
4.67%
-458.6%
View Full Analysis

About HLF

Founded
1980
Employees
8500
CEO
Stephan Gratziani
WebsiteView website
www.herbalife.com

Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products. The company also provides literature, promotional, and other materials, such as start-up kits, sales tools, and educational materials. It sells its products through sales representatives, independent service providers, and company-operated retail stores and platforms. The company was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. Herbalife Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

Recent HLF News & Updates

Narrative Update Jun 18

HLF: Execution On 2026 Guidance And Margins Will Drive Stock Rebound

Analysts have lifted their price target on Herbalife to about $18.33 from $17.50, citing updated assumptions around discount rates, expected revenue growth, profit margins, and future P/E multiples reflected in recent research. Analyst Commentary Recent research on Herbalife highlights a mix of optimism around execution and valuation, alongside ongoing caution about the company’s ability to sustain and convert growth assumptions into consistent earnings.

Recent updates

No updates